HEPSEEVAX

Welcome to the Brand page for “HEPSEEVAX”, which is offered here for The mark consists of the wording hepseevax with a hexagon incorporating triangles.;pharmaceutical and medicinal preparations and substances for infectious diseases, hiv, malaria, hepatitis c and tuberculosis; vaccines against hepatitis c;color is not claimed as a feature of the mark.;the wording hepseevax has no meaning in a foreign language.;hepcvax;product research and development; medical research; pharmaceutical research; diagnostic research and development in the field of infectious diseases, hiv, malaria, tuberculosis and hepatitis including hepatitis c; consulting in the fields of medical and pharmaceutical research; medical research and development; medical research and development relating to the treatment of hiv, malaria, tuberculosis and hepatitis including hepatitis c; product research and development in the field of birthing and nutrition; provision of information in relation to the foregoing;.

Its status is currently believed to be active. Its class is unavailable. “HEPSEEVAX” is believed to be currently owned by “The Macfarlane Burnet Institute for Medical Research and Public Health Limited”.

Owner:
THE MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH LIMITED
Owner Details
Description:
The mark consists of the wording HEPSEEVAX with a hexagon incorporating triangles.;Pharmaceutical and medicinal preparations and substances for infectious diseases, HIV, malaria, hepatitis C and tuberculosis; vaccines against hepatitis C;Color is not claimed as a feature of the mark.;The wording HEPSEEVAX has no meaning in a foreign language.;HEPCVAX;Product research and development; medical research; pharmaceutical research; diagnostic research and development in the field of infectious diseases, HIV, malaria, tuberculosis and hepatitis including hepatitis C; consulting in the fields of medical and pharmaceutical research; medical research and development; medical research and development relating to the treatment of HIV, malaria, tuberculosis and hepatitis including hepatitis C; product research and development in the field of birthing and nutrition; provision of information in relation to the foregoing;
Categories: